SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-013590
Filing Date
2020-11-12
Accepted
2020-11-12 06:52:04
Documents
49
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q swtx-20200930x10q.htm 10-Q 1511400
2 EX-31.1 swtx-20200930ex311e34f41.htm EX-31.1 11643
3 EX-31.2 swtx-20200930ex312f5f2ec.htm EX-31.2 11638
4 EX-32.1 swtx-20200930ex3215e270d.htm EX-32.1 7454
5 EX-32.2 swtx-20200930ex322d33c53.htm EX-32.2 7431
  Complete submission text file 0001558370-20-013590.txt   3782241

Data Files

Seq Description Document Type Size
6 EX-101.INS swtx-20200930.xml EX-101.INS 473736
7 EX-101.SCH swtx-20200930.xsd EX-101.SCH 27453
8 EX-101.CAL swtx-20200930_cal.xml EX-101.CAL 38814
9 EX-101.DEF swtx-20200930_def.xml EX-101.DEF 85124
10 EX-101.LAB swtx-20200930_lab.xml EX-101.LAB 280838
11 EX-101.PRE swtx-20200930_pre.xml EX-101.PRE 192260
Mailing Address 100 WASHINGTON BOULEVARD STAMFORD CT 06902
Business Address 100 WASHINGTON BOULEVARD STAMFORD CT 06902 203-883-9490
SpringWorks Therapeutics, Inc. (Filer) CIK: 0001773427 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39044 | Film No.: 201303241
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences